Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cochlear Implant Aids the Profoundly Deaf

By HospiMedica staff writers
Posted on 02 Mar 2006
A ribbon-like cochlear implant could greatly improve hearing for profoundly deaf patients and also simplify insertion, helping surgeons minimize damage to healthy ear tissue. More...


A team at the University of Michigan (Ann Arbor, MI, USA) made the implant and embedded thin-film electrode sites that directly stimulate the auditory nerve. The implant is currently being tested in guinea pigs and cats, said team leader Kensall D. Wise, director of the Center for Wireless Integrated Microsystems (WIMS, Ann Arbor, MI, USA), who also holds appointments in the departments of biomedical engineering, electrical engineering, and computer science at the university. The device may be available in four to five years for use in humans.

Approximately 100,000 patients to date have received cochlear implants worldwide. The current technology, Dr. Wise noted, is bulky, difficult for surgeons to insert, and does not allow a great range of perceived frequencies. The present implants use electrodes formed from a bundle of wires fed into the snail-shaped cochlea of the inner ear, and each implant has anywhere from 16 to 22 stimulating sites along its length. By contrast, the new implant will host up to 128 stimulating sites.

The range of frequencies that can be stimulated depends on how far into the cochlea the implant can go, with the lower frequencies located further up toward the apex of the spiral canal, said Dr. Wise. More sites mean greater tonal range and better frequency perception, and the implant's flexibility will minimize damage to existing hearing.

The ribbon film technology lets researchers embed other functions in the implant, such as position sensors that allow surgeons to watch the implant's progress on a monitor as they are feeding it into the cochlea. The implant can be manufactured by the same process used in making integrated circuits, which means it can be mass produced.



Related Links:
University of Michigan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.